Literature DB >> 11901854

Molecular detection and genotyping of human papillomavirus.

L J van Doorn1, B Kleter, W G Quint.   

Abstract

Human papillomavirus infections are associated with the development of cervical neoplasia. Human papillomavirus is a group of heterogeneous viruses, comprising many genotypes, which can be divided into high-risk and low-risk types, depending on their association with disease. Therefore, accurate molecular diagnostic tools are required for detection and identification of human papillomavirus. Monitoring of human papillomavirus infection is necessary for adequate patient management and follow-up during treatment. This review describes the different molecular methods available for human papillomavirus detection and identification of genotypes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11901854     DOI: 10.1586/14737159.1.4.394

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  11 in total

1.  Viral and microbial genotyping by a combination of multiplex competitive hybridization and specific extension followed by hybridization to generic tag arrays.

Authors:  Baback Gharizadeh; Max Käller; Pål Nyrén; Anders Andersson; Mathias Uhlén; Joakim Lundeberg; Afshin Ahmadian
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

2.  Type-specific multiple sequencing primers: a novel strategy for reliable and rapid genotyping of human papillomaviruses by pyrosequencing technology.

Authors:  Baback Gharizadeh; Maria Oggionni; Biying Zheng; Edit Akom; Nader Pourmand; Afshin Ahmadian; Keng-Ling Wallin; Pål Nyrén
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

3.  Human papillomavirus infection in female sex workers in Lima, Peru.

Authors:  Silvia M Montano; Evelyn J Hsieh; Martha Calderón; Thanh G N Ton; Eberth Quijano; Vicky Solari; Joseph R Zunt
Journal:  Sex Transm Infect       Date:  2010-09-02       Impact factor: 3.519

4.  Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays.

Authors:  Jan Wallace; Bruce A Woda; German Pihan
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

5.  Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.

Authors:  Leen-Jan van Doorn; Anco Molijn; Bernhard Kleter; Wim Quint; Brigitte Colau
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

6.  Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA.

Authors:  Maurits de Koning; Wim Quint; Linda Struijk; Bernhard Kleter; Patrick Wanningen; Leen-Jan van Doorn; Sönke Jan Weissenborn; Mariet Feltkamp; Jan ter Schegget
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

7.  Human papillomavirus infection in men who have sex with men in Lima, Peru.

Authors:  Roswell Quinn; Javier Salvatierra; Vicky Solari; Martha Calderon; Thanh G N Ton; Joseph R Zunt
Journal:  AIDS Res Hum Retroviruses       Date:  2012-06-01       Impact factor: 2.205

8.  Sentinel-base DNA genotyping using multiple sequencing primers for high-risk human papillomaviruses.

Authors:  Baback Gharizadeh; Biying Zheng; Michael Akhras; Mehran Ghaderi; Olufisayo Jejelowo; Björn Strander; Pål Nyrén; Keng-Ling Wallin; Nader Pourmand
Journal:  Mol Cell Probes       Date:  2006-03-03       Impact factor: 2.365

9.  Prevalence of human papilloma virus and their high-risk genotypes in Sri Lankan women.

Authors:  K A S N Shanaka; S Wilathgamuwa; Y I N S Gunawardene; R S Dassanayake
Journal:  Virusdisease       Date:  2018-02-15

10.  Long-term follow-up of HPV16-positive women: persistence of the same genetic variant and low prevalence of variant co-infections.

Authors:  Daan T Geraets; Leen-Jan van Doorn; Bernhard Kleter; Brigitte Colau; Diane M Harper; Wim G V Quint
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.